Methods and materiale for assessing prostate cancer therapies

Details for Australian Patent Application No. 2004305075 (hide)

Owner The Regents of the University of California

Inventors Charles, L. Sawyers; Derek, Welsbie; Charlie, D. Chen

Agent Freehills

Pub. Number AU-A-2004305075

PCT Pub. Number WO2005/060661

Priority 60/531,091 19.12.03 US

Filing date 16 December 2004

Wipo publication date 7 July 2005

International Classifications

A61K 31/70 (2006.01) - Carbohydrates

A01N 43/04 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

20 July 2006 PCT application entered the National Phase

  PCT publication WO2005/060661 Priority application(s): WO2005/060661

10 August 2006 Amendment Made

  The nature of the amendment is: Amend the invention title to read Methods and materials for assessing prostate cancer therapies

8 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004305079-3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors

2004305069-Mitotic kinesin inhibitors